Trilogy Capital’s iShares ESG Screened S&P Mid-Cap ETF XJH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.57M Buy
30,195
+1,467
+5% +$72.5K 0.06% 170
2026
Q1
$1.3M Buy
28,728
+2,327
+9% +$109K 0.06% 172
2025
Q4
$1.18M Sell
26,401
-1,188
-4% -$52.4K 0.05% 174
2025
Q3
$1.21M Sell
27,589
-87
-0.3% -$3.75K 0.06% 167
2025
Q2
$1.15M Buy
27,676
+442
+2% +$17.4K 0.06% 166
2025
Q1
$1.06M Buy
+27,234
New +$1.13M 0.06% 166

Other funds holding XJH

Trilogy Capital's XJH Position: Q2 2026 in Review

Trilogy Capital increased its iShares ESG Screened S&P Mid-Cap ETF (XJH) stake by 5.1% in Q2 2026, buying an estimated $72.5K and bringing the position to 30,195 shares worth $1.57M. The position accounts for 0.06% of the portfolio, ranked #170.

Trilogy Capital first reported a position in XJH in Q1 2025 and has held it in 6 quarters since. 194 funds tracked by Wall St. Rank hold XJH as of Q2 2026.

  • Trilogy Capital held 30,195 shares of iShares ESG Screened S&P Mid-Cap ETF worth $1.57M as of Q2 2026.
  • Trilogy Capital bought 1,467 iShares ESG Screened S&P Mid-Cap ETF shares in Q2 2026, an estimated $72.5K.
  • iShares ESG Screened S&P Mid-Cap ETF made up 0.06% of Trilogy Capital's portfolio in Q2 2026, its #170 holding.
  • Trilogy Capital first reported a position in iShares ESG Screened S&P Mid-Cap ETF in Q1 2025 and has held it in 6 quarters since.
  • 194 funds tracked by Wall St. Rank held iShares ESG Screened S&P Mid-Cap ETF as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.